Medline Inc. (MDLN)

About Medline Inc.

Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 392 institutions reported holding MDLN, with 749.5 million shares worth $29.6 billion in aggregate. The largest reported holders were The Carlyle Group, H&F Corporate Investors X, Ltd and FMR. Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.

More on MDLN

• MDLN sentiment: whether news and social coverage of Medline Inc. leans bullish or bearish, and the stories driving it.
• MDLN ownership: all 392 reporting institutions, plus insider and congressional trades.
• MDLN financials: revenue, net income, operating margin and free cash flow by quarter and year.

SentiSense also tracks daily options readings for Medline Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.

Frequently asked questions